001     136018
005     20240229105050.0
024 7 _ |a 10.1016/j.celrep.2018.05.045
|2 doi
024 7 _ |a pmid:29898408
|2 pmid
024 7 _ |a altmetric:43676448
|2 altmetric
037 _ _ |a DKFZ-2018-00718
041 _ _ |a eng
082 _ _ |a 570
100 1 _ |a Bormann, Felix
|0 P:(DE-He78)b8cddb2a2d44b0f670d05b482f2a8b08
|b 0
|e First author
|u dkfz
245 _ _ |a Cell-of-Origin DNA Methylation Signatures Are Maintained during Colorectal Carcinogenesis.
260 _ _ |a Maryland Heights, MO
|c 2018
|b Cell Press
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1659529386_29253
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a DKFZ-ZMBH-Allianz
520 _ _ |a Colorectal adenomas are precursor lesions of colorectal cancers and represent clonal amplifications of single cells from colonic crypts. DNA methylation patterns specify cell-type identity during cellular differentiation and, therefore, provide opportunities for the molecular analysis of tumors. We have now analyzed DNA methylation patterns in colorectal adenomas and identified three biologically defined subclasses that describe different intestinal crypt differentiation stages. Importantly, colorectal carcinomas could be classified into the same methylation subtypes, reflecting their shared cell types of origin with adenomas. Further data analysis also revealed significantly reduced overall survival for one of the subtypes. Our results provide a concept for understanding the methylation patterns observed in colorectal cancer and provide opportunities for tumor subclassification and patient stratification.
536 _ _ |a 311 - Signalling pathways, cell and tumor biology (POF3-311)
|0 G:(DE-HGF)POF3-311
|c POF3-311
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
700 1 _ |a Rodríguez-Paredes, Manuel
|0 P:(DE-HGF)0
|b 1
700 1 _ |a Lasitschka, Felix
|b 2
700 1 _ |a Edelmann, Dominic
|0 P:(DE-He78)92820b4867c955a04f642707ecf35b40
|b 3
|u dkfz
700 1 _ |a Musch, Tanja
|0 P:(DE-He78)8c6aa915aae944911892509166968bde
|b 4
|u dkfz
700 1 _ |a Benner, Axel
|0 P:(DE-He78)e15dfa1260625c69d6690a197392a994
|b 5
|u dkfz
700 1 _ |a Bergman, Yehudit
|b 6
700 1 _ |a Dieter, Sebastian
|0 P:(DE-He78)34c336827b750ba10a020fd62ec4664f
|b 7
|u dkfz
700 1 _ |a Ball, Claudia
|0 P:(DE-He78)7a10ea1b9b2872da9f375002c44ddfce
|b 8
|u dkfz
700 1 _ |a Glimm, Hanno
|0 P:(DE-He78)157277fe62f07df1732f9d126a51d1b9
|b 9
|u dkfz
700 1 _ |a Linhart, Heinz G
|0 P:(DE-HGF)0
|b 10
700 1 _ |a Lyko, Frank
|0 P:(DE-He78)a8d53a8cdc716390a6cbacdead227143
|b 11
|e Last author
|u dkfz
773 _ _ |a 10.1016/j.celrep.2018.05.045
|g Vol. 23, no. 11, p. 3407 - 3418
|0 PERI:(DE-600)2649101-1
|n 11
|p 3407 - 3418
|t Cell reports
|v 23
|y 2018
|x 2211-1247
909 C O |p VDB
|o oai:inrepo02.dkfz.de:136018
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 0
|6 P:(DE-He78)b8cddb2a2d44b0f670d05b482f2a8b08
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 1
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 3
|6 P:(DE-He78)92820b4867c955a04f642707ecf35b40
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 4
|6 P:(DE-He78)8c6aa915aae944911892509166968bde
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 5
|6 P:(DE-He78)e15dfa1260625c69d6690a197392a994
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 7
|6 P:(DE-He78)34c336827b750ba10a020fd62ec4664f
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 8
|6 P:(DE-He78)7a10ea1b9b2872da9f375002c44ddfce
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 9
|6 P:(DE-He78)157277fe62f07df1732f9d126a51d1b9
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 10
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 11
|6 P:(DE-He78)a8d53a8cdc716390a6cbacdead227143
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-311
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-300
|4 G:(DE-HGF)POF
|v Signalling pathways, cell and tumor biology
|x 0
914 1 _ |y 2018
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b CELL REP : 2015
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
915 _ _ |a Creative Commons Attribution-NonCommercial-NoDerivs CC BY-NC-ND (No Version)
|0 LIC:(DE-HGF)CCBYNCNDNV
|2 V:(DE-HGF)
|b DOAJ
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b CELL REP : 2015
920 1 _ |0 I:(DE-He78)A130-20160331
|k A130
|l A130 Epigenetik
|x 0
920 1 _ |0 I:(DE-He78)C060-20160331
|k C060
|l C060 Biostatistik
|x 1
920 1 _ |0 I:(DE-He78)G911-20160331
|k G911
|l NCT DD Translationale Medizinische Onkologie
|x 2
920 1 _ |0 I:(DE-He78)L301-20160331
|k L301
|l DKTK Dresden
|x 3
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)A130-20160331
980 _ _ |a I:(DE-He78)C060-20160331
980 _ _ |a I:(DE-He78)G911-20160331
980 _ _ |a I:(DE-He78)L301-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21